公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2004 | Cardiac involvement in malignancies: Case 1. Favorable outcome of a patient with cardiac invasion from non-small-cell lung carcinoma | MIN-SHAN TSAI ; PATRICK CHOW-IN KO ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; SHYR-CHYR CHEN ; WEN-CHU CHIANG ; WEN-JONE CHEN | Journal of Clinical Oncology | 4 | 4 | |
2024 | CD44s and CD44v8-10 isoforms confer acquired resistance to osimertinib by activating the ErbB3/STAT3 signaling pathway | Liu, Yi-Nan; Tsai, Meng-Feng; SHANG-GIN WU ; Chang, Tzu-Hua; JIN-YUAN SHIH | Life sciences | |||
2021 | Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel | Huang J.-W.; CHING-HUA KUO ; Kuo H.-C.; JIN-YUAN SHIH ; Tsai T.-W.; LIN-CHAU CHANG | PLoS ONE | 6 | 4 | |
2010 | Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors | CHIA-CHI LIN ; Hsu H.-H.; Sun C.-T.; JIN-YUAN SHIH ; ZHONG-ZHE LIN ; CHONG-JEN YU ; Chen G.G.; Hsin M.K.Y.; Lam K.C.; Leung L.; CHIH-HSIN YANG ; Mok T. | Journal of Thoracic Oncology | 26 | 22 | |
2015 | Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion | TZU-HSIU TSAI ; SHANG-GIN WU ; MIN-SHU HSIEH ; CHONG-JEN YU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | Lung Cancer | 42 | 38 | |
2011 | Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: A combined clinical-molecular pathological approach | Salto-Tellez M.; Tsao M.-S.; JIN-YUAN SHIH ; Thongprasert S.; Lu S.; Chang G.-C.; Au J.S.-K.; Chou T.-Y.; Lee J.-S.; Shi Y.-K.; Radzi A.; Kang J.-H.; Kim S.-W.; Tan S.-Y.; CHIH-HSIN YANG | Journal of Thoracic Oncology | 35 | 36 | |
2014 | Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations | YEN-FU CHEN ; MIN-SHU HSIEH ; SHANG-GIN WU ; YIH-LEONG CHANG ; JIN-YUAN SHIH ; Liu Y.-N.; Tsai M.-F.; TZU-HSIU TSAI ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG | Journal of Thoracic Oncology | 68 | 64 | |
2019 | Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: A case-control observational study | YUNG-HSUAN CHEN ; YEN-FU CHEN ; CHUNG-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | BMC Cancer | 16 | 11 | |
2020 | Clinical factors associated with treatment toxicity of pemetrexed plus platinum in elderly patients with non-small cell lung cancer | CHUNG-YU CHEN ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | Journal of the Formosan Medical Association | 5 | 4 | |
2019 | Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations | YEN-TING LIN ; JIN-SHING CHEN ; WEI-YU LIAO ; CHAO-CHI HO ; CHIA-LIN HSU ; Yang C.-Y.; KUAN-YU CHEN ; JIH-HSIANG LEE ; ZHONG-ZHE LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | International Journal of Cancer | 53 | 46 | |
2020 | Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer | WEN-CHI YANG ; Feng-Ming Hsu ; YU-HSUAN CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU ; ZHONG-ZHE LIN ; Lu S.-H.; CHIH-HSIN YANG ; ANN-LII CHENG ; SUNG-HSIN KUO | Clinical and Translational Radiation Oncology | 11 | 8 | |
2012 | Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR | KUEI-PIN CHUNG ; SHANG-GIN WU ; Wu J.-Y.; CHIH-HSIN YANG ; CHONG-JEN YU ; Wei P.-F.; JIN-YUAN SHIH ; PAN-CHYR YANG | Clinical Cancer Research | 58 | 55 | |
2022 | Clinical outcomes of Atezolizumab Therapy for Previously-Treated Advanced-Stage Non-Small Cell Lung Cancer: A Real-World Study in Taiwan | SHANG-GIN WU ; Chiang, Chi-Lu; Wang, Chin-Chou; Hung, Jen-Yu; Hsia, Te-Chun; Kuo, Chih-Hsi; JIN-YUAN SHIH | Journal of Cancer | 1 | 1 | |
2008 | Clinical response of gefitinib on malignant pleural effusions in patients with non-small cell lung cancer | Chen C.-H.; Gow C.-H.; CHONG-JEN YU ; JIN-YUAN SHIH ; Hsu Y.-C.; Lee W.-Y.; PAN-CHYR YANG ; Kuo S.-H. | Journal of Cancer Molecules | 8 | ||
2012 | Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment | KUEI-PIN CHUNG ; Huang Y.-T.; YIH-LEONG CHANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; YEUN-CHUNG CHANG ; JIN-YUAN SHIH ; PAN-CHYR YANG | Chest | 44 | 42 | |
2014 | Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension | MONG-WEI LIN ; CHEN-TU WU ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; PAN-CHYR YANG | Journal of Surgical Oncology | 32 | 29 | |
2021 | Clinicopathologic Features and Response to Therapy of NRG1 Fusion–Driven Lung Cancers: The eNRGy1 Global Multicenter Registry | Drilon A.; Duruisseaux M.; Han J.-Y.; Ito M.; Falcon C.; Yang S.-R.; Murciano-Goroff Y.R.; Chen H.; Okada M.; Molina M.A.; Wislez M.; Brun P.; Dupont C.; Branden E.; Rossi G.; Schrock A.; Ali S.; Gounant V.; Magne F.; Blum T.G.; Schram A.M.; Monnet I.; JIN-YUAN SHIH ; Sabari J.; Pérol M.; Zhu V.W.; Nagasaka M.; Doebele R.; Camidge D.R.; Arcila M.; Ou S.-H.I.; Moro-Sibilot D.; Rosell R.; Muscarella L.A.; Liu S.V.; Cadranel J. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 29 | 20 | |
2021 | Clinicopathological features and survival outcomes of primary pulmonary invasive mucinous adenocarcinoma | Gow C.-H.; MIN-SHU HSIEH ; Liu Y.-N.; Lee Y.-H.; JIN-YUAN SHIH | Cancers | 10 | 8 | |
2011 | Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations | Yuan S.; SUNG-LIANG YU ; Chen H.-Y.; Hsu Y.-C.; KANG-YI SU ; HUEI-WEN CHEN ; Chen C.-Y.; CHONG-JEN YU ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; PAN-CHYR YANG | Journal of Clinical Oncology | 28 | 26 | |
2016 | Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis | Chen L.-Y.; Molina-Vila M.A ; SHENG-YUAN RUAN ; KANG-YI SU ; WEI-YU LIAO ; KAI-LUN YU ; CHAO-CHI HO ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHIH-HSIN YANG ; Rosell R.; PAN-CHYR YANG | Lung Cancer | 57 | 52 |